ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 C56.9

Billable / Specific HCC v28: 10 CC

Malignant neoplasm of unspecified ovary

C56
Block
0
Synonyms
1,065
LCDs
52
Payer Policies
14
Linked CPTs

About ICD-10-CM C56.9

ICD-10-CM code C56.9 represents Malignant neoplasm of unspecified ovary. This is a billable/specific code in the chapter (block C56). The 2026 edition of ICD-10-CM C56.9 became effective on October 1, 2025.

Coding Tips for C56.9

Specialist guidance from the PayerReady Medical Coding Team. Specificity warnings, HCC capture rules, sequencing notes.

HCC capture: document with MEAT each year

C56.9 is a CMS-HCC v28 risk-adjustment code (category 10). To count for the patient Risk Adjustment Factor (RAF), document the diagnosis with MEAT language each calendar year: Monitored, Evaluated, Assessed, Treated. A diagnosis on the problem list alone does not satisfy CMS RADV audit standards. Include the diagnosis in the assessment with current status and current treatment plan.

Inpatient DRG impact: CC

C56.9 is designated CC for MS-DRG grouping. On inpatient claims, this code can shift the DRG to the with-CC variant when documented as a present-on-admission secondary diagnosis. Hospital CDI programs flag CC opportunities during chart review. Failure to capture this code may leave 30 to 80 percent of the inpatient stay revenue unrealized.

Medicare Advantage HCC Impact

CMS-HCC v28 (current)
Category 10
ESRD-HCC
Category 10
RxHCC (Part D)
Category 10

Capture this diagnosis annually for accurate risk adjustment. Missed HCC captures are the #1 revenue leak in Medicare Advantage risk programs.

Inpatient DRG Impact, CC

codes Malignant neoplasm of unspecified ovary. As a Complication/Comorbidity (CC), this contributes to DRG severity adjustment when documented alongside the principal diagnosis.

Medicare LCD Coverage for C56.9

Local Coverage Determinations (LCDs) from CMS MACs that list C56.9 as a covered diagnosis.

1,065 LCDs

Showing top 10 of 1,065 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
Article ID: 60240, Effective: , 680 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
Article ID: 60309, Effective: , 680 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
Article ID: 55294, Effective: 2026-02-19 00:00:00, 68 covered, 0 non-covered
CPT 81162 →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 0179U →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 81479 →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 81462 →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 81445 →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 0571U →
CMS LCD: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
Article ID: 57867, Effective: 2025-07-01 00:00:00, 622 covered, 0 non-covered
CPT 0485U →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing C56.9.

52 policies

5 Medicare

Billing and Coding: Bevacizumab and biosimilars
Policy ID: ART-52370
Billing and Coding: Paclitaxel (e.g., Taxol�/Abraxane �)
Policy ID: ART-52450
Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
Policy ID: ART-52453
Oral Anticancer Drugs - Policy Article
Policy ID: ART-52479
Billing and Coding: Biomarkers for Oncology
Policy ID: ART-52986

CPT Codes Commonly Billed with C56.9

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

14 linkages
  • J1952 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J3316 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • 96402 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J9219 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J9225 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J9218 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J1950 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • J1954 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • 11983 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD
  • 11982 CMS LCD: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs CMS LCD

Convert C56.9 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
C56.9 1830 10000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 C56.9, Billing FAQ

Is ICD-10 code C56.9 billable? +

Yes, C56.9 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

Does C56.9 affect Medicare Advantage HCC risk adjustment? +

Yes. C56.9 maps to CMS-HCC v28 category 10. Capture this diagnosis annually for accurate Medicare Advantage risk score.

Is C56.9 a CC or MCC for inpatient DRG? +

Yes, this code is designated as CC. Documenting as a secondary diagnosis on inpatient claims can shift the DRG to a higher-weighted category.

What CPT codes are commonly billed with C56.9? +

Procedures frequently paired with C56.9 include: J1952, J3316, 96402, J9219, J9225.

What ICD-9 codes does C56.9 map to? +

Per CMS GEMs, C56.9 maps to ICD-9 codes: 1830. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on May 31, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included